Sort
16,179 grants matching “malaria”
Chemopreventive therapy for malaria in HIV uninfected children
$388,570Matthew G Dorsey · University Of California, San Francisco · P01 · FY2012 · HD
Molecular Analysis of Plasmodium vivax Surface Antigens
$388,518Emory University · R01 · FY2001 · AI
Anopheles responses to Plasmodium infected blood
$388,458George Dimopoulos Dimopoulos · Johns Hopkins University · R01 · FY2007 · AI
HIV Drugs and Their Impact on Malaria Infection and Immunity
$388,431Charlotte Hobbs · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Collaborative Research: ASSESSING THE SYSTEMATICS AND DIVERSITY OF HAEMOSPORIDA IN AFRICAN LIZARDS
$388,229Aaron M Bauer · Villanova University · · FY2022 · BIO
Evaluation of Novel PE Malaria Vaccine Candidates
$388,200Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
The Germinal Center and T cell help in Three Phases of Clearance of Plasmodium
$388,058Robin Stephens · University Of Texas Med Br Galveston · R01 · FY2018 · AI
Prenatal Iron Supplements: Safety & Efficacy in Tanzania
$388,042Wafaie W Fawzi · Harvard School Of Public Health · U01 · FY2011 · HD
IL-27 in Vaccine-Elicited Cellular Immunity
$388,021Ross M Kedl · University Of Colorado Denver · R01 · FY2015 · AI
Center for dynamic RNA epitranscriptomes - Covid 19 Supplement Version 2
$388,014Chuan He · University Of Chicago · RM1 · FY2020 · HG
Designing HTA therapy for drug resistant malaria
$388,000Georgetown University · R01 · FY2005 · AI
The Universidade Eduardo Mondlane/UCSD Medical Education Partnership
$388,000Emilia Virginia Noormahomed · Eduardo Mondlane University · R24 · FY2013 · TW
Host Immunity to EBV Infection in Vitro and in Vivo
$387,750David A Thorley-Lawson · Tufts University Boston · R01 · FY2013 · AI
EFFECTOR AND MEMORY ANTIMALARIA CD8+ CELL RESPONSES
$387,726New York University School Of Medicine · R01 · FY2001 · AI
Computational Structure-Based Protein Design
$387,721Bruce R. Donald · Duke University · R01 · FY2016 · GM
A Trial of Zinc and Micronutrients in Tanzanian Children
$387,663Christopher P Duggan · Harvard School Of Public Health · R01 · FY2008 · HD
PLASMODIUM VIVAX MSP-3 AND MSP-9 AS VACCINE IMMUNOGENES
$387,571Mary R Galinski · Emory University · R01 · FY2006 · AI
Molecular mechanism of juvenile hormone action in mosquito reproduction
$387,570Jinsong Zhu · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · AI
Development, characterization and application of CRISPR/Cas9 gene drive technologies and related active genetic elements to benefit research and society at large
$387,500Valentino Matteo Gantz · University Of California, San Diego · DP5 · FY2018 · OD
Development, characterization and application of CRISPR/Cas9 gene drive technologies and related active genetic elements to benefit research and society at large
$387,500Valentino Matteo Gantz · University Of California, San Diego · DP5 · FY2020 · OD
Discovery of chemically validated malaria liver stage targets
$387,500Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2014 · AI
Development, characterization and application of CRISPR/Cas9 gene drive technologies and related active genetic elements to benefit research and society at large
$387,500Valentino Matteo Gantz · University Of California, San Diego · DP5 · FY2017 · OD
Development, characterization and application of CRISPR/Cas9 gene drive technologies and related active genetic elements to benefit research and society at large
$387,500Valentino Matteo Gantz · University Of California, San Diego · DP5 · FY2019 · OD
Discovery of chemically validated malaria liver stage targets
$387,292Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2012 · AI
Immune Signatures Associated with Plasmodium falciparum Control Following Natural
$387,228Margaret Juliana McElrath · Seattle Biomedical Research Institute · U19 · FY2013 · AI